Myong Cheol Lim

75PUBLICATIONS
268CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (75)

|Jan 29, 2026
Maintenance of PARP Inhibitor Rechallenge plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.

Hyun-Woong Cho, Jeong-Yeol Park, Myong Cheol Lim

|Jan 23, 2026
Prognostic value and adjuvant treatment outcomes for the use of the JGOG prognostic model in early-stage intermediate-risk cervical cancer: a Korean Gynecologic Oncology Group study (KGOG 1028).

Uisuk Kim, Jaekyung Bae, E Sun Paik

|Dec 11, 2025
Pattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy.

Ji Hyun Kim, Eun Taeg Kim, Heon Jong Yoo

|Oct 29, 2025
Influence of Residual Disease on the Efficacy of PARP Inhibitors in Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta Analysis.

Sekyoung Hwang, Ji Hyun Kim, Uisuk Kim

|Aug 22, 2025
Efficacy and toxicity of PARP inhibitor in elderly patients with homologous recombination-deficient newly diagnosed advanced ovarian cancer: the role of dose modification.

Ji Hyun Kim, Dongkyu Eugene Kim, Uisuk Kim

|Aug 12, 2025
Impact of <i>Clostridium difficile</i> Infection on Chemotherapy in Patients With Primary Ovarian Cancer.

Jaekyung Bae, Eun Young Park, Uisuk Kim

Pageof 13

Frequent Collaborators

19 joint publications

Sang-Yoon Park

16 joint publications

Ji Hyun Kim

13 joint publications

Jung-Yun Lee

13 joint publications

Jae-Weon Kim